NF-kappaB: a key role in inflammatory diseases.
Journal: 2001/February - Journal of Clinical Investigation
ISSN: 0021-9738
Relations:
Content
Citations
(707)
References
(45)
Diseases
(1)
Conditions
(1)
Chemicals
(3)
Genes
(1)
Organisms
(2)
Processes
(1)
Affiliates
(2)
Similar articles
Articles by the same authors
Discussion board
J Clin Invest 107(1): 7-11

NF-κB: a key role in inflammatory diseases

Division of Clinical Immunology and Rheumatology, Academic Medical Center, Amsterdam, The NetherlandsDivision of Rheumatology, Allergy and Immunology, University of California at San Diego School of Medicine, La Jolla, California, USA
Address correspondence to: Paul P. Tak, Division of Clinical Immunology and Rheumatology, Academic Medical Center, PO Box 22700, 1100 DE Amsterdam, The Netherlands, Phone: +31-20-5662171; Fax: +31-20-6919658; E-mail: ln.avu.cma@kaT.P.P.
Address correspondence to: Paul P. Tak, Division of Clinical Immunology and Rheumatology, Academic Medical Center, PO Box 22700, 1100 DE Amsterdam, The Netherlands, Phone: +31-20-5662171; Fax: +31-20-6919658; E-mail: ln.avu.cma@kaT.P.P.

Activation of the NF-κB/Rel transcription family, by nuclear translocation of cytoplasmic complexes, plays a central role in inflammation through its ability to induce transcription of proinflammatory genes (1). This pathway is activated upon appropriate cellular stimulation, most often by signals related to pathogens or stress. Here we will discuss the specificity of various NF-κB proteins, their role in inflammatory disease, the regulation of NF-κB activity by IκB proteins and IκB kinase (IKK), and the development of therapeutic strategies aimed at inhibition of NF-κB.

References

  • 1. Baldwin AS., Jr The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol. 1996;14:649–683.[PubMed]
  • 2. Chen F, Castranova V, Shi X, Demers LMNew insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem. 1999;45:7–17.[PubMed][Google Scholar]
  • 3. Franzoso G, et al Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 1997;11:3482–3496.[Google Scholar]
  • 4. Vincenti MP, Coon CI, Brinckerhoff CENuclear factor kappaB/p50 activates an element in the distal matrix metalloproteinase 1 promoter in interleukin-1beta-stimulated synovial fibroblasts. Arthritis Rheum. 1998;41:1987–1994.[PubMed][Google Scholar]
  • 5. Miyazawa K, Mori A, Yamamoto K, Okudaira HConstitutive transcription of the human interleukin-6 gene by rheumatoid synoviocytes: spontaneous activation of NF-kappa B and CBF1. Am J Pathol. 1998;152:793–803.[Google Scholar]
  • 6. Rahman A, Anwar KN, True AL, Malik ABThrombin-induced p65 homodimer binding to downstream NF-kappa B site of the promoter mediates endothelial ICAM-1 expression and neutrophil adhesion. J Immunol. 1999;162:5466–5476.[PubMed][Google Scholar]
  • 7. Schottelius AJ, Mayo MW, Sartor RB, Baldwin AS., Jr Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem. 1999;274:31868–31874.[PubMed]
  • 8. Li Z, Nabel GJA new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription. Mol Cell Biol. 1997;17:6184–6190.[Google Scholar]
  • 9. Spiecker M, Darius H, Liao JKA functional role of I kappa B-epsilon in endothelial cell activation. J Immunol. 2000;164:3316–3322.[PubMed][Google Scholar]
  • 10. Zandi E, Chen Y, Karin MDirect phosphorylation of IkappaB by IKKalpha and IKKbeta: discrimination between free and NF-kappaB-bound substrate. Science. 1998;281:1360–1363.[PubMed][Google Scholar]
  • 11. Yamaoka S, et al Complementation cloning of NEMO, a component of the IkappaB kinase complex essential for NF-kappaB activation. Cell. 1998;93:1231–1240.[PubMed][Google Scholar]
  • 12. Shimada T, et al IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IkappaB kinases. Int Immunol. 1999;11:1357–1362.[PubMed][Google Scholar]
  • 13. Chen Z, et al Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway. Genes Dev. 1995;9:1586–1597.[PubMed][Google Scholar]
  • 14. Thompson JE, Phillips RJ, Erdjument-Bromage H, Tempst P, Ghosh SI kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell. 1995;80:573–582.[PubMed][Google Scholar]
  • 15. Aupperle KR, et al NF-kB regulation by IkB kinase in primary fibroblast-like synoviocytes. J Immunol. 1999;163:427–433.[PubMed][Google Scholar]
  • 16. Li ZW, et al The IKKbeta subunit of IkappaB Kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med. 1999;189:1839–1845.[Google Scholar]
  • 17. Lavon I, et al High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-kappaB activation. Nat Med. 2000;6:573–577.[PubMed][Google Scholar]
  • 18. Hu Y, et al Abnormal morphogenesis but intact IKK activation in mice lacking the IKKalpha subunit of IkappaB kinase. Science. 1999;284:316–320.[PubMed][Google Scholar]
  • 19. Delhase M, Hayakawa M, Chen Y, Karin MPositive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science. 1999;284:309–313.[PubMed][Google Scholar]
  • 20. Tojima Y, et al NAK is an IkappaB kinase-activating kinase. Nature. 2000;404:778–782.[PubMed][Google Scholar]
  • 21. Aronica MA, et al Preferential role for NF-kappa B/Rel signaling in the type 1 but not type 2 T cell-dependent immune response in vivo. J Immunol. 1999;163:5116–5124.[PubMed][Google Scholar]
  • 22. Chen CC, Rosenbloom CL, Anderson DC, Manning AMSelective inhibition of E-selectin, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 expression by inhibitors of I kappa B-alpha phosphorylation. J Immunol. 1995;155:3538–3545.[PubMed][Google Scholar]
  • 23. Kasibhatla S, et al DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappa B and AP-1. Mol Cell. 1998;1:543–551.[PubMed][Google Scholar]
  • 24. Miagkov AV, et al NF-kappaB activation provides the potential link between inflammation and hyperplasia in the arthritic joint. Proc Natl Acad Sci USA. 1998;95:13859–13864.[Google Scholar]
  • 25. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS., Jr NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science. 1998;281:1680–1683.[PubMed]
  • 26. Romashkova JA, Makarov SSNF-kappaB is a target of AKT in anti-apoptotic PDGF signalling. Nature. 1999;401:86–90.[PubMed][Google Scholar]
  • 27. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CEInterleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum. 2000;43:801–811.[PubMed][Google Scholar]
  • 28. Yokoo T, Kitamura MDual regulation of IL-1 beta-mediated matrix metalloproteinase-9 expression in mesangial cells by NF-kappa B and AP-1. Am J Physiol. 1996;270:F123–F130.[PubMed][Google Scholar]
  • 29. Han ZN, Boyle DL, Manning AM, Firestein GSAP-1 and NF-kappa B regulation in rheumatoid arthritis and murine collagen-induced arthritis. Autoimmunity. 1998;28:197–208.[PubMed][Google Scholar]
  • 30. Tsao PW, et al The effect of dexamethasone on the expression of activated NF-kappa B in adjuvant arthritis. Clin Immunol Immunopathol. 1997;83:173–178.[PubMed][Google Scholar]
  • 31. Tak PP, et al IkB kinase-2 (IKK-2) is a key regulator of synovial inflammation. Arthritis Rheum. 1999;42:S400. (Abstr.) [PubMed][Google Scholar]
  • 32. Gerlag DM, et al Effect of a T cell specific NF-kB inhibitor on in vitro cytokine production and collagen-induced arthritis. J Immunol. 2000;165:1652–1658.[PubMed][Google Scholar]
  • 33. Sakurai H, et al Activation of transcription factor NF-kappa B in experimental glomerulonephritis in rats. Biochim Biophys Acta. 1996;1316:132–138.[PubMed][Google Scholar]
  • 34. Yang F, de Villiers WJ, Lee EY, McClain CJ, Varilek GWIncreased nuclear factor-kappaB activation in colitis of interleukin-2-deficient mice. J Lab Clin Med. 1999;134:378–385.[PubMed][Google Scholar]
  • 35. Yang L, et al Essential role of nuclear factor kappaB in the induction of eosinophilia in allergic airway inflammation. J Exp Med. 1998;188:1739–1750.[Google Scholar]
  • 36. Donovan CE, et al NF-kappa B/Rel transcription factors: c-Rel promotes airway hyperresponsiveness and allergic pulmonary inflammation. J Immunol. 1999;163:6827–6833.[PubMed][Google Scholar]
  • 37. Hart LA, Krishnan VL, Adcock IM, Barnes PJ, Chung KFActivation and localization of transcription factor, nuclear factor-kappaB, in asthma. Am J Respir Crit Care Med. 1998;158:1585–1592.[PubMed][Google Scholar]
  • 38. van Den Brink GR, et al Expression and activation of NF-kappa B in the antrum of the human stomach. J Immunol. 2000;164:3353–3359.[PubMed][Google Scholar]
  • 39. Neurath MF, et al Cytokine gene transcription by NF-kappa B family members in patients with inflammatory bowel disease. Ann NY Acad Sci. 1998;859:149–159.[PubMed][Google Scholar]
  • 40. Mattson, M.P., and Camandola, S. 2001. NF-κB in neuronal plasticity and neurodegenerative disorders. J. Clin. Invest. In press.
  • 41. Collins, T., and Cybulsky, M.I. 2001. NF-κB: pivotal mediator or innocent bystander in atherogenesis? J. Clin. Invest. In press.
  • 42. Tomita T, et al Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappa B decoy oligodeoxynucleotides as a gene therapy. Arthritis Rheum. 1999;42:2532–2542.[PubMed][Google Scholar]
  • 43. Seetharaman R, Mora AL, Nabozny G, Boothby M, Chen JEssential role of T cell NF-kappa B activation in collagen-induced arthritis. J Immunol. 1999;163:1577–1583.[PubMed][Google Scholar]
  • 44. Neurath MF, Pettersson S, Meyer zum Buschenfelde KH, Strober WLocal administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med. 1996;2:998–1004.[PubMed][Google Scholar]
  • 45. Yamamoto, Y., and Gaynor, R.B. 2001. Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer. J. Clin. Invest. In press.
  • 46. Firestein GS, Manning AMSignal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 1999;42:609–621.[PubMed][Google Scholar]
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.